Quoin Pharmaceuticals (QNRX) Intangibles (2020 - 2026)
Quoin Pharmaceuticals (QNRX) posted Intangibles of $1.0 million for Q1 2026, little changed sequentially from $1.0 million in Q4 2025, and up 118.18% YoY from $458334.0 in Q1 2025.
Quoin Pharmaceuticals (QNRX) Intangibles (2020 - 2026) Analysis & Trends
Quoin Pharmaceuticals has reported Intangibles for 7 years, with the latest figure at $1.0 million in Q1 2026.
- Quarterly Intangibles rose 118.18% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 118.18% YoY) and the FY2025 annual result came in at $1.0 million, up 106.9% from the prior year.
- Intangibles held at $1.0 million in Q1 2026 per QNRX's latest filing, from $1.0 million in the prior quarter.
- Over five years, Intangibles peaked at $1.0 million in Q4 2025 and troughed at $408334.0 in Q3 2025.
- A 5-year average of $632250.4 and a median of $604931.5 in 2023 frame the typical range for Intangibles.
- The sharpest annual moves came in 2025 and 2026: Intangibles dropped 19.67% in 2025, then jumped 118.18% in 2026.
- Over 5 years, Intangibles stood at $704561.0 in 2022, then dropped by 17.21% to $583334.0 in 2023, then retreated by 17.14% to $483334.0 in 2024, then surged by 106.9% to $1.0 million in 2025, then changed by 0.0% to $1.0 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $1.0 million, $1.0 million, and $408334.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Quoin Pharmaceuticals | 531,643.73 | 531,643.73 | - | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 408,334.00 |
| Jun 30, 2025 | 433,334.00 |
| Mar 31, 2025 | 458,334.00 |
| Dec 31, 2024 | 483,334.00 |
| Sep 30, 2024 | 508,334.00 |
| Jun 30, 2024 | 533,334.00 |
| Mar 31, 2024 | 558,334.00 |
| Dec 31, 2023 | 583,334.00 |
| Sep 30, 2023 | 626,529.00 |
| Jun 30, 2023 | 652,539.00 |
| Mar 31, 2023 | 678,550.00 |
| Dec 31, 2022 | 704,561.00 |
| Sep 30, 2022 | 730,572.00 |
| Jun 30, 2022 | 756,583.00 |
| Dec 31, 2021 | 808,604.00 |
| Dec 31, 2020 | 912,648.00 |